1. Abbreviations used: T22, [Tyr5,12 Lys7]-polyphemusin II; TW70, des-[Cys8,13, Tyr9,12]-[d-Lys10, Pro11]-T22); HIV, human immunodeficiency virus; AZT, 3′-azido-2′, 3′-dideoxythymidine; AIDS, acquired immunodeficiency syndrome; EC50, 50% effective concentration; CC50, 50% cytotoxic concentration; Fmoc, 9-fluorenylmethyloxycarbonyl; DIPCDI, 1,3-diisopropylcarbodiimide; HOBt, N-hydroxybenzotriazole; Alko, p-benzyloxybenzyl alcohol; But, tert-butyl; Mtr, 4-methoxy-2,3,6-trimethylphenylsulfonyl; MBzl, 4-methoxybenzyl; TMSBr, trimethylsilyl bromide; SI, selectivity index; IC50, 50% inhibitory concentration; IF, immunofluorescence; TFA, trifluoroacetic acid; DMF, N,N-dimethylformamide; ddC, 2′,3′-dideoxycytidine.
2. Mitsuya H. J Clin Exp Med (Tokyo) 1996;176:108.
3. (a) Nakamura T, Furunaka H, Miyata T, Tokunaga F, Muta T, Iwanaga S, Niwa M, Takao T, Shimonishi Y. J Biol Chem 1988;263:16709 (b) Miyata T, Tokunaga F, Yoneya T, Yoshikawa K, Iwanaga S, Niwa M, Takao T, Shimonishi Y. J Biochem 1989;106:663 (c) Muta T, Fujimoto T, Nakajima H, Iwanaga S. ibid 1990;108:261.
4. (a) Morimoto M, Mori H, Otake T, Ueba N, Kunita N, Niwa M, Murakami T, Iwanaga S. Chemotherapy 1991;37:206 (b) Murakami T, Niwa M, Tokunaga F, Miyata T, Iwanaga S. ibid 1991;37:327.
5. (a) Masuda M, Nakashima H, Ueda T, Naba H, Ikoma R, Otaka A, Terakawa Y, Tamamura H, Ibuka T, Murakami T, Koyanagi Y, Waki M, Matsumoto A, Yamamoto N, Funakoshi S, Fujii N. Biochem Biophys Res Commun 1992;189:845 (b) Tamamura H, Otaka A, Takada W, Terakawa Y, Yoshizawa H, Masuda M, Ibuka T, Murakami T, Nakashima H, Waki M, Matsumoto A, Yamamoto N, Fujii N. Chem Pharm Bull 1995;43:12 (c) Tamamura H, Otaka A, Murakami T, Ibuka T, Sakano K, Waki M, Matsumoto A, Yamamoto N, Fujii N. Biochem Biophys Res Commun 1996;229:648.